News
Novo Nordisk A/S’s decision to stop making insulin pens will narrow treatment options for children with diabetes unless ...
Indian drug companies are increasing their presence in the insulin market. They are competing with multinational corporations ...
Read more about Novo Nordisk's stock moves and today's market action. After years of being known for its insulin and diabetes products, Novo Nordisk produced what some have deemed an ...
7d
Clinical Trials Arena on MSNNovo Nordisk’s Sogroya matches Norditropin in children’s growth disordersNovo Nordisk’s once-weekly Sogroya (somapacitan) has proved to be non-inferior to the once-daily growth hormone Norditropin ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results